Learn more →
Back to Expert Scholars
Translational Medicine / 转化医学Gastroesophageal Cancer, Perioperative Chemo

David Cunningham

MD

🏢Royal Marsden Hospital🌐UK

Consultant Medical Oncologist

62
h-index
0
Key Papers
0
Key Contributions

👥Biography 个人简介

David Cunningham at Royal Marsden contributed to establishing perioperative chemotherapy as standard of care for resectable gastroesophageal cancer through the MAGIC trial (ECF chemotherapy). His extensive research on chemotherapy regimens, HER2-targeted therapy, and novel agents in gastroesophageal cancers has shaped upper GI cancer treatment globally.

Share:

🧪Research Fields 研究领域

perioperative chemotherapy gastric
FLOT gastric esophageal
MAGIC trial gastric
ECF chemotherapy gastric
esophagogastric cancer treatment

🎓Key Contributions 主要贡献

Representative Works 代表性著作

📄Data Sources 数据来源

Last updated: 2026-03-01 | All information from publicly available academic sources

关注 David Cunningham 的研究动态

Follow David Cunningham's research updates

留下邮箱,当我们发布与 David Cunningham(Royal Marsden Hospital)相关的新研究或访谈时,我们会通知你。

我们不会泄露你的信息,也不会发送无关内容。随时可以退订。

Explore More Experts

Discover the researchers shaping the future of cancer treatment